The Deuterium Isotope Effect and its Role in Drug Discovery

Abstract

The substitution of hydrogen with deuterium — a stable, non-radioactive isotope — represents a subtle and mechanistically powerful strategy in modern drug discovery. This webinar will introduce DMPK scientists and medicinal chemists to the kinetic isotope effect (KIE), exploring the physicochemical basis by which the stronger C–D bond can attenuate drug metabolism and influence a compound's pharmacokinetic profile. Drawing on both preclinical and clinical examples, attendees will gain an appreciation for how deuterium incorporation can be leveraged in drug design and as a mechanistic probe for identifying the site of metabolism. The presentation will also address the limitations of this approach — including metabolic switching and when to expect scenarios where no isotope effect is observed. Attendees will leave with a practical, foundational framework for evaluating when and how deuterium substitution can be a meaningful tool in their DMPK and medicinal chemistry toolkit. 

Educational Needs Statement

The kinetic isotope effect is well known across the industry; however, it is a nuanced subject that can sometimes be misunderstood, inappropriately utilized in an attempt to solve metabolic liabilities, or simply conjured up as a magic fix-all. For a complex subject such as this, one that can be quite useful when applied at the right time and for the right reason, our industry would benefit from a refresher on this subject. The goal of this webinar is to educate on the kinetic isotope effect as a tool for drug discovery. 

Learning Objectives

Educate DMPK scientists and medicinal chemists about the kinetic isotope effect and using deuterium for Medicinal Chemistry design in Drug Discovery. By the end of this webinar, the audience will have a foundational understanding of what the effect is and in what circumstances it can be employed to improve the DM properties of a drug candidate.